Working… Menu

Phase I Study of Safety and Immunogenicity of ADU-623

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01967758
Recruitment Status : Completed
First Posted : October 23, 2013
Last Update Posted : August 17, 2018
Aduro Biotech, Inc.
Information provided by (Responsible Party):
Providence Health & Services

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 18, 2018
Actual Study Completion Date : August 15, 2018